DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR MS Speaks
       *****************************************************
   DIR (Abst.) Transitioning from intravenous to subcutaneous ocreliz...
       0 replies
   DIR Efficacy and safety of higher dose of ocrelizumab in RMS and P...
       0 replies
   DIR Reinitiating ocrelizumab with a full 600mg dose after extended...
       0 replies
   DIR Could Roche's Ocrevus be doing more harm than good in women w/...
       0 replies
   DIR Case series highlights potential cumulative pulmonary risk wit...
       0 replies
   DIR (Abst.) Recurrence of disease activity after ocrelizumab disco...
       1 replies
   DIR (Abst.) Cardiogenic shock after ocrelizumab infusion in RRMS (...
       1 replies
   DIR Severe late-onset neutropenia in a patient with MS treated wit...
       0 replies
   DIR (ECTRIMS) Ocrelizumab may double serious infection risk in MS
       0 replies
   DIR (ACTRIMS abst.) MS patients treated with ocrelizumab, aged 70 ...
       1 replies
       *****************************************************
       Page 1 of 10
   DIR Next Page